Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial was to find the best dose of N-acetylcysteine (NAC) to decrease
brain injury in babies exposed to intrauterine infection without causing significant side
effects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)